Perceptive Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-52,724
| Closed | -$716K | – | 125 |
|
|
2020
Q2 | $716K | Buy |
+52,724
| New | +$716K | 0.01% | 114 |
|
|
2019
Q2 | – | Sell |
-1,703,440
| Closed | -$14M | – | 105 |
|
|
2019
Q1 | $14M | Hold |
1,703,440
| – | – | 0.39% | 49 |
|
|
2018
Q4 | $9.18M | Sell |
1,703,440
-746,081
| -30% | -$4.02M | 0.35% | 54 |
|
|
2018
Q3 | $21.6M | Buy |
2,449,521
+234,121
| +11% | +$2.07M | 0.58% | 41 |
|
|
2018
Q2 | $22.1M | Sell |
2,215,400
-247,000
| -10% | -$2.47M | 0.58% | 46 |
|
|
2018
Q1 | $23.5M | Buy |
2,462,400
+475,000
| +24% | +$4.53M | 0.66% | 37 |
|
|
2017
Q4 | $29.6M | Buy |
1,987,400
+357,400
| +22% | +$5.31M | 0.98% | 26 |
|
|
2017
Q3 | $32.1M | Buy |
1,630,000
+530,000
| +48% | +$10.4M | 1.22% | 18 |
|
|
2017
Q2 | $15.8M | Buy |
1,100,000
+1,050,376
| +2,117% | +$15.1M | 0.8% | 35 |
|
|
2017
Q1 | $457K | Sell |
49,624
-487,632
| -91% | -$4.49M | 0.03% | 121 |
|
|
2016
Q4 | $5.59M | Sell |
537,256
-271,840
| -34% | -$2.83M | 0.4% | 57 |
|
|
2016
Q3 | $7.3M | Sell |
809,096
-84,504
| -9% | -$762K | 0.47% | 52 |
|
|
2016
Q2 | $6.68M | Buy |
893,600
+28,600
| +3% | +$214K | 0.46% | 45 |
|
|
2016
Q1 | $7.79M | Buy |
865,000
+605,000
| +233% | +$5.45M | 0.68% | 36 |
|
|
2015
Q4 | $3.36M | Hold |
260,000
| – | – | 0.25% | 60 |
|
|
2015
Q3 | $2.51M | Buy |
+260,000
| New | +$2.51M | 0.2% | 61 |
|